JACOB GAARE: Open Payments
NPI 1265108740 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,153 in 95 payments from 16 companies in 2025. Trend: 2023 $1,560 · 2024 $2,153 · 2025 $2,153
Food & beverage: $2,044Education: $110
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $415 |
| GENZYME CORPORATION | 6 | $214 |
| Amgen Inc. | 7 | $191 |
| ABBVIE INC. | 16 | $176 |
| Janssen Biotech, Inc. | 6 | $174 |
| LEO Pharma Inc. | 8 | $159 |
| Arcutis Biotherapeutics, Inc. | 8 | $157 |
| Incyte Corporation | 9 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| Lilly USA, LLC | 5 | $123 |
Products named: DUPIXENT, TREMFYA, Zoryve, OPZELURA, SKYRIZI, ADBRY, OTEZLA, COSENTYX.
Industry payments across AZ — which companies pay providers there.
